Rohto Pharmaceutical Co(RPHCF)
$15.27-0.72 (-4.53%)
RPHCF
Rohto Pharmaceutical Co earnings date
$15.27
At close:-0.72 (-4.53%)
Rohto Pharmaceutical Co (RPHCF) Q4 2019 Earnings Report
3 Followers
RPHCF Q4 2019 EPS Results
- Actual EPS
- $0.12
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.04
RPHCF Q4 2019 Revenue Results
- Actual Revenue
- $462.08M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +3.90%
Earnings Announcement Details
- Quarter
- Q4 2019
- Date
- 05/12/2020
- Time
- TBA
- Conference Call
- Tuesday, May 12, 2020
RPHCF Upcoming Earnings
Rohto Pharmaceutical Co's next earnings date is estimated for February 12, 2027, based on past reporting schedules.
Q4 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
RPHCF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 12, 2027 | 2026 (Q3) | 0.33- | 0.29 | ― | ― |
| Nov 12, 2026 | 2026 (Q2) | 0.200.16 | 0.16 | -0.35% (-0.00) | |
| Aug 06, 2026 | 2026 (Q1) | 0.250.29 | 0.33 | -9.50% (-0.03) | |
| May 13, 2026 | 2025 (Q4) | 0.190.17 | 0.17 | -3.54% (-0.01) | |
| Feb 12, 2026 | 2025 (Q3) | 0.280.29 | 0.33 | -9.71% (-0.03) | |
| Nov 13, 2025 | 2025 (Q2) | 0.160.16 | 0.12 | 33.76% (+0.04) | |
| Aug 06, 2025 | 2025 (Q1) | ―0.33 | 0.23 | 40.10% (+0.09) | |
| May 13, 2025 | 2024 (Q4) | 0.160.17 | 0.13 | 30.69% (+0.04) | |
| Feb 12, 2025 | 2024 (Q3) | 0.310.33 | 0.26 | 24.26% (+0.06) | |
| Nov 13, 2024 | 2024 (Q2) | 0.220.12 | 0.21 | -40.83% (-0.08) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
